Hematopoietic Cell Transplantation in a Patient With X‐Linked Chronic Granulomatous Disease With McLeod Phenotype
- 21 April 2025
- journal article
- case report
- Published by Wiley in Pediatric Transplantation
- Vol. 29 (3) , e70086
Abstract
Background: X‐linked chronic granulomatous disease (X‐CGD) may be associated with McLeod syndrome (MLS) as a contiguous gene deletion syndrome. MLS is characterized by the loss of XK protein along with Kx antigen on red blood cell (RBC) surfaces and late‐onset neurocognitive symptoms. RBCs in healthy donors express XK protein and related Kx antigen on the surface; therefore, transfusion from random donors to patients with MLS poses a risk of Kx sensitization, leading to severe hemolysis. As the radical treatment of X‐CGD is hematopoietic cell transplantation (HCT), treating patients with coexisting X‐CGD and MLS is extremely challenging.Method: A retrospective chart review was completed for a case of X‐CGD associated with MLS who underwent HCT.Result: A 7‐year‐old boy with X‐CGD and MLS underwent HCT from a matched unrelated donor (human leukocyte antigen, 7/8 matched). Rituximab was added to busulfan‐based reduced intensity conditioning to prevent Kx sensitization. Donor RBCs were depleted from the bone marrow before infusion to prevent Kx sensitization. Neutrophil engraftment was achieved on day +19 with full donor chimerism. No hemolytic events occurred, and he is living well 2 years after HCT.Conclusion: We were able to safely perform transplantation in a patient with X‐CGD and MLS by adding rituximab and depleting RBCs from the donor bone marrow. The long‐term impact of HCT on MLS is unclear. However, HCT may improve prognosis and quality of life by reducing recurrent infections caused by X‐CGD. Moreover, this HCT method is non‐invasive, relatively simple, and easily implementable.Keywords
All Related Versions
Funding Information
- National Center for Child Health and Development
This publication has 11 references indexed in Scilit:
- Chronic Granulomatous Disease with the McLeod Phenotype: a French National Retrospective Case SeriesJournal of Clinical Immunology, 2020
- Molecular Basis and Clinical Overview of McLeod Syndrome Compared With Other Neuroacanthocytosis SyndromesJAMA Neurology, 2018
- Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (REDS‐III) databaseBritish Journal of Haematology, 2018
- Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre studyThe Lancet, 2014
- Chronic granulomatous disease, the McLeod phenotype and the contiguous gene deletion syndrome-a reviewClinical and Molecular Allergy, 2011
- Residual NADPH Oxidase and Survival in Chronic Granulomatous DiseaseNew England Journal of Medicine, 2010
- Successful hematopoietic stem-cell transplantation in a patient with chronic granulomatous disease and McLeod phenotype sensitized to Kx and K antigensBone Marrow Transplantation, 2009
- Successful donor-lymphocyte infusion for extreme immune-hemolysis following unrelated BMT in a patient with X-linked chronic granulomatous disease and McLeod phenotypeBone Marrow Transplantation, 2008
- Treatment of McLeod Phenotype Chronic Granulomatous Disease with Reduced-Intensity Conditioning and Unrelated-Donor Umbilical Cord Blood TransplantationInternational Journal of Hematology, 2007
- Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiencyHuman Genetics, 2000